Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

VEXT Science Inc. (C:VEXT)

Business Focus: Pharmaceuticals (NEC)

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for VEXT within the last 6 months
See all filings within the past 6 months

Company News

Mar 22, 2023 06:30 ET
Vext Generates Solid Operating Performance in Fiscal 2022 - Continued Growth in Adjusted EBITDA
Vancouver, British Columbia--(Newsfile Corp. - March 22, 2023) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("VEXT" or the "Company") a U.S.-based cannabis operator with vertical operations in Arizona and Ohio1, today reported its financial results for the period ended December 31, 2022. All currency references used in this news release are in U.S. currency unless otherwise noted.
Read full article
Mar 06, 2023 07:30 ET
Vext to Announce Financial Results for Q4 and Fiscal 2022 on March 22, 2023
Vancouver, British Columbia--(Newsfile Corp. - March 6, 2023) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio1, today announced that it plans to release its financial results for the period ended December 31, 2022 before market open on March 22, 2023.
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Mar 15, 202330,982-19,667
Feb 28, 202350,64926,045
Feb 15, 202324,604-11,072
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Vext Science, Inc. is a cannabis tetrahydrocannabinol (THC) and hemp cannabinoid products company. The Company manufactures THC cartridges, concentrates, edibles and accessories under the Vapen brand, and hemp-based products under the Pure Touch Botanicals brand as well as the Vapen CBD brand. It has THC concentrates, edibles, and distillate cartridge brands sold in various states dispensaries. It owns a 100% interest in two vertically integrated cannabis operations in Arizona. Additionally, it provides management, advisory, cultivation, and dispensary services to entities in the cannabis field through joint operations agreements. It is also engaged in selling CBD products and branded merchandise. Vapen Brands product is the wholesale product and sold in its dispensaries as well as others. The Vapen Brand is an edible and concentrate brand. Flower, unless, as a preroll or infused, is sold primarily in its retail operations. Vapen Brands also distributes Wynk and Major beverages.

See business summary



Search (past week) for $VEXT.CA